CATALYST PHARMACEUTICALS, INC. 3 SEC Filings

Filed On	Filing
08 Aug 2025	Form 3: Curran Daniel J., Director Holds 0 shares of Common Stock, par value $0.001 per share
06 Jun 2025	Form 3: Andrews William T., Chief Medical Officer Holds 0 shares of Common Stock, par value $0.001 per share
26 Feb 2025	Form 3: Russo Gregg, Chief HR Officer Holds 0 shares of Common Stock, par value $0.001 per share
03 Jan 2024	Form 3: Kalb Michael Wayne, Executive Vice President & CFO Holds 0 shares of Common Stock, par value $0.001 per share
05 Jun 2023	Form 3: Thompson Tamar, Director
13 Jul 2021	Form 3: Sundaram Preethi, Chief Product Devel. Officer
08 Jul 2021	Form 3: Harper Molly, Director
02 Jul 2020	Form 3: Del Carmen Jeffrey, Chief Commercial Officer
04 Jan 2019	Form 3: Elsbernd Brian, Chief Compliance/Legal Officer
15 Jun 2018	Form 3: Brennan Daniel, Chief Commercial Officer Holds 3,094 shares of Common Stock, par value $0.001 per share
16 Sep 2015	Form 3: Merrigan Paul J, Chief Commercial Officer
07 Jul 2015	Form 3: Ingenito Gary, Chief Medical Officer
02 Mar 2015	Form 3: Daly Richard J, Director
02 Mar 2015	Form 3: Denkhaus Donald A, Director
05 Sep 2014	Form 3: Muth David D, Exec. V.P., Corp. Development Holds 10,000 shares of Common Stock, par value $0.001 per share
13 Nov 2012	Form 3: Biomarin Pharmaceutical Inc, 10% owner
22 Nov 2011	Form 3: Rieger Richard, VP Commercial Operations
11 Jun 2007	Form 3: Miller Steve, VP Development & Management Holds 72,960 shares of Common Stock
11 Jun 2007	Form 3: Grande Alicia, Chief Accounting Officer Holds 15,000 shares of Common Stock
23 Oct 2006	Form 3: Winship M Douglas, V.P. of Regulatory Operations Holds 0 shares of No securities beneficially owned

Comments